Systemic Bioavailability and Potency of High-Dose Inhaled Corticosteroids
- 1 May 1999
- Vol. 115 (5) , 1278-1284
- https://doi.org/10.1378/chest.115.5.1278
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patientsThorax, 1997
- Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionateThe Lancet, 1996
- Effects of Inhaled Fluticasone Propionate and Oral Prednisolone on Lymphocyte β2-Adrenoceptor Function in Asthmatic PatientsChest, 1996
- New perspectives on inhaled drug delivery and systemic bioactivity.Thorax, 1995
- Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients.Thorax, 1995
- The influence of orally deposited budesonide on the systemic availability of budesonide after inhalation from a Turbuhaler.British Journal of Clinical Pharmacology, 1993
- Importance of the inhalation device on the effect of budesonide.Archives of Disease in Childhood, 1993
- Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction.Thorax, 1993
- Inhaled corticosteroids: benefits and risks.Thorax, 1992
- Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler.Thorax, 1991